Lipocine
LPCN
LPCN
27 hedge funds and large institutions have $3.17M invested in Lipocine in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
63% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 19
76% less capital invested
Capital invested by funds: $13M → $3.17M (-$9.85M)
Holders
27
Holding in Top 10
–
Calls
$39K
Puts
$49K
Top Buyers
| 1 | +$125K | |
| 2 | +$98K | |
| 3 | +$92K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$72.2K |
| 5 |
Barclays
London,
United Kingdom
|
+$61K |
Top Sellers
| 1 | -$2.31M | |
| 2 | -$1.33M | |
| 3 | -$1.28M | |
| 4 |
RA
Royce & Associates
New York
|
-$489K |
| 5 |
Millennium Management
New York
|
-$460K |